X
X

Hubli

Hubli
Sl. No Principal Investigator’s Name Study Title Phase Protocol ID Indication Study Status Contact person & Phone Number
1 Dr Vishal Kulkarni A Multicenter, Double-Blind, Randomized, Parallel-Group, Active-Controlled, Two Part, Phase III, Global Study to Evaluate the Pharmacokinetics, Efficacy and Safety of BP02 (Trastuzumab) in comparison wit+D15h Herceptin®-EU in Patients with HER2-Positive Early Breast Cancer (EBC) and HER2-Positive Metastatic Breast Cancer (MBC). Phase 3 CR-201-18 HER2-Positive Metastatic Breast Cancer (MBC). Ongoing with Recruitment Prasad/9550939397
2 Dr Vinaykumar Muttagi A global, multicenter, three arms, open-label randomized study to evaluate the efficacy and safety of Nanosomal Docetaxel Lipid Suspension compared to Taxotere® (Docetaxel Injection Concentrate) in triple-negative breast cancer patients with locally advanced or metastatic breast cancer after failure to prior chemotherapy. Phase 3 0063-17 “triple-negative breast cancer patients with locally advanced or metastatic breast cancer after failure to prior chemotherapy.” Ongoing with Recruitment Manisha/9030545730
3 Dr Vishal Kulkarni Collection of blood and tissue samples from subjects diagnosed with Esophageal Cancer to evaluate biomarker expression profiles NA SLS – GNE – 01 “Esophageal Adenocarcinoma & Esophageal Squamous Cell Carcinoma” Ongoing with Recruitment Meghana/7996393350
4 Dr Vishal Kulkarni Collection of blood samples from subjects diagnosed with Non-Small Cell Lung Carcinoma to evaluate biomarker expression profiles NA SLS – GNE – 02 “Non-Small Cell Lung Carcinoma “ Ongoing with Recruitment Meghana/7996393350
5 Dr Vishal Kulkarni A Phase IIb/III, Randomised, Double-blind, Placebo-controlled, Multicentre, Study of CA-170 in Combination with Chemotherapy and Radiation in Patients with Unresectable Stage III or IVa Non-Squamous Non-Small Cell Lung Cancer (ASIAD-2) Phase 2b/3 CA-170-301 “Stage III or IVa Non-Squamous Non-Small Cell Lung Cancer “ Ongoing with Recruitment Manjunath /9845764235

To get in touch with the Clinical Trials Team at HCG, please call on +91 80 4020 6000 (extn: 6058)

Research and Trials

To know more about facilities available for patients at HCG

HCG Call Icon